NASDAQ : VRXA
VERAXA Biotech AG — Financial statements
Healthcare · Biotechnology · Germany
Last price 1.16 USD (Oct 30, 2026, 2:22 PM EDT) · Market cap 164.03M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
VERAXA Biotech AG (VRXA) reported revenue of 23.43K CHF (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in CHF.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Revenue | 23.43K | 23.43K | ||
| Cost of Revenue | 7.96K | 7.96K | ||
| Gross Profit | 15.46K | 15.46K | ||
| Selling, General & Admin | 53.87M | 53.87M | 20.73M | 10.55M |
| Research & Development | 10.26M | 10.26M | 6.31M | 4.26M |
| Operating Expenses | 66.23M | 66.23M | 28.92M | 16.66M |
| Operating Income | -66.22M | -66.22M | -28.92M | -16.66M |
| Interest Expense | -3.55K | -3.55K | -291.00 | -1.09K |
| Currency Exchange Gain (Loss) | -41.55K | -41.55K | 624.15K | -1.05M |
| Other Non Operating Income (Expenses) | 54.25K | 54.25K | 14.81K | 54.35K |
| EBT Excluding Unusual Items | -66.21M | -66.21M | -28.28M | -17.66M |
| Other Unusual Items | -799.17K | -799.17K | -474.54K | |
| Pretax Income | -67.01M | -67.01M | -28.75M | -17.66M |
| Income Tax Expense | -392.60K | -392.60K | -620.77K | -1.11M |
| Net Income | -66.61M | -66.61M | -28.13M | -16.54M |
| Net Income to Common | -66.61M | -66.61M | -28.13M | -16.54M |
| Shares Outstanding (Basic) | 14.47M | 14.47M | 14.05M | 13.73M |
| Shares Outstanding (Diluted) | 14.47M | 14.47M | 14.05M | 13.73M |
| EPS (Basic) | -4.60 | -4.60 | -2.00 | -1.21 |
| EPS (Diluted) | -4.60 | -4.60 | -2.00 | -1.21 |
| Free Cash Flow | -10.34M | -10.34M | -7.84M | -7.50M |
| Free Cash Flow Per Share | -0.71 | -0.71 | -0.56 | -0.55 |
| Gross Margin | 66.00% | 66.00% | ||
| Operating Margin | -282,662.75% | -282,662.75% | ||
| Profit Margin | -284,359.22% | -284,359.22% | ||
| Free Cash Flow Margin | -44,136.89% | -44,136.89% | ||
| EBITDA | -64.24M | -64.24M | -27.05M | -14.82M |
| D&A For EBITDA | 1.97M | 1.97M | 1.87M | 1.84M |
| EBIT | -66.22M | -66.22M | -28.92M | -16.66M |
Balance sheet
Fiscal year January - December; amounts in CHF.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Cash & Equivalents | 1.61M | 1.61M | 5.36M | 11.35M |
| Cash & Short-Term Investments | 1.61M | 1.61M | 5.36M | 11.35M |
| Other Receivables | 1.17M | 1.17M | 174.87K | 257.76K |
| Receivables | 1.17M | 1.17M | 174.87K | 257.76K |
| Prepaid Expenses | 100.24K | 100.24K | 68.81K | 268.27K |
| Total Current Assets | 2.88M | 2.88M | 5.61M | 11.88M |
| Property, Plant & Equipment | 3.11M | 3.11M | 2.83M | 2.13M |
| Goodwill | 22.85M | 22.85M | 22.85M | 22.85M |
| Other Intangible Assets | 51.91M | 51.91M | 53.49M | 55.08M |
| Other Long-Term Assets | 70.72K | 70.72K | ||
| Total Assets | 80.82M | 80.82M | 84.77M | 91.94M |
| Accounts Payable | 1.39M | 1.39M | 488.54K | 611.58K |
| Accrued Expenses | 951.04K | 951.04K | 372.88K | 503.76K |
| Current Portion of Leases | 257.10K | 257.10K | 156.40K | |
| Current Income Taxes Payable | 535.55K | 535.55K | 427.59K | 390.73K |
| Other Current Liabilities | 3.48M | 3.48M | 1.10M | 101.49K |
| Total Current Liabilities | 6.61M | 6.61M | 2.55M | 1.61M |
| Long-Term Leases | 883.55K | 883.55K | 708.08K | |
| Long-Term Deferred Tax Liabilities | 14.44M | 14.44M | 15.17M | 15.79M |
| Other Long-Term Liabilities | 74.65M | 74.65M | 35.29M | 19.41M |
| Total Liabilities | 96.59M | 96.59M | 53.71M | 36.81M |
| Common Stock | 14.75M | 14.75M | 14.18M | 13.41M |
| Additional Paid-In Capital | 68.25M | 68.25M | 48.96M | |
| Retained Earnings | -98.48M | -98.48M | -31.86M | -3.73M |
| Comprehensive Income & Other | -291.52K | -291.52K | -222.50K | 45.45M |
| Shareholders' Equity | -15.77M | -15.77M | 31.05M | 55.13M |
| Total Liabilities & Equity | 80.82M | 80.82M | 84.77M | 91.94M |
| Total Debt | 1.14M | 1.14M | 864.49K | |
| Net Cash (Debt) | 473.34K | 473.34K | 4.50M | 11.35M |
| Net Cash Per Share | 0.03 | 0.03 | 0.32 | 0.83 |
| Filing Date Shares Outstanding | 14.75M | 14.75M | 14.18M | 13.73M |
| Total Common Shares Outstanding | 14.75M | 14.75M | 14.18M | 13.73M |
| Working Capital | -3.73M | -3.73M | 3.06M | 10.27M |
| Book Value Per Share | -1.07 | -1.07 | 2.19 | 4.02 |
| Tangible Book Value | -90.52M | -90.52M | -45.28M | -22.80M |
| Tangible Book Value Per Share | -6.14 | -6.14 | -3.19 | -1.66 |
| Machinery | 3.20M | 3.20M | 2.99M | 2.87M |
| Construction In Progress | 7.73K | 7.73K | 7.73K | 7.73K |
| Leasehold Improvements | 207.78K | 207.78K |
Cash flow statement
Fiscal year January - December; amounts in CHF.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Net Income | -66.61M | -66.61M | -28.13M | -16.54M |
| Depreciation & Amortization | 1.97M | 1.97M | 1.87M | 1.84M |
| Other Amortization | 156.00 | 156.00 | 7.60K | 9.85K |
| Loss (Gain) From Sale of Assets | 17.45K | 17.45K | 27.60K | |
| Stock-Based Compensation | 52.66M | 52.66M | 18.33M | 7.61M |
| Other Operating Activities | 880.25K | 880.25K | -257.79K | 508.03K |
| Change in Accounts Payable | 902.39K | 902.39K | -123.03K | -355.53K |
| Change in Other Net Operating Assets | 1.00M | 1.00M | 561.13K | 525.87K |
| Operating Cash Flow | -9.90M | -9.90M | -7.72M | -7.27M |
| Capital Expenditures | -437.18K | -437.18K | -120.88K | -232.31K |
| Cash Acquisitions | -784.12K | |||
| Investing Cash Flow | -437.18K | -437.18K | -120.88K | -1.02M |
| Short-Term Debt Issued | 1.00M | 1.00M | ||
| Total Debt Issued | 1.00M | 1.00M | ||
| Long-Term Debt Repaid | -164.64K | -164.64K | ||
| Lease Payments | -164.64K | -164.64K | ||
| Net Debt Issued (Repaid) | 835.36K | 835.36K | ||
| Issuance of Common Stock | 5.76M | 5.76M | 1.85M | 12.54M |
| Financing Cash Flow | 6.59M | 6.59M | 1.85M | 12.54M |
| Net Cash Flow | -3.75M | -3.75M | -5.99M | 4.25M |
| Free Cash Flow | -10.34M | -10.34M | -7.84M | -7.50M |
| Free Cash Flow Margin | -44,136.89% | -44,136.89% | ||
| Free Cash Flow Per Share | -0.71 | -0.71 | -0.56 | -0.55 |
| Levered Free Cash Flow | 15.75M | 15.75M | 3.07M | |
| Unlevered Free Cash Flow | 15.75M | 15.75M | 3.07M | |
| Free Cash Flow After Leases | -10.50M | -10.50M | -7.84M | -7.50M |
| Change in Working Capital | 1.18M | 1.18M | 438.10K | -694.33K |
Ratios
Fiscal year January - December; amounts in CHF.
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Market Capitalization | 161.20M | 337.44M | 316.88M | |
| Enterprise Value | 160.61M | 332.47M | ||
| Last Close Price | 1.14 | 10.67 | 10.02 | |
| PS Ratio | 5,456.62 | 11,422.01 | ||
| PB Ratio | -16.97 | 9.25 | ||
| EV/Sales Ratio | 5,436.41 | 11,253.99 | ||
| Debt / Equity Ratio | -0.07 | -0.07 | 0.03 | |
| Net Debt / Equity Ratio | 0.03 | 0.03 | -0.14 | -0.21 |
| Net Debt / EBITDA Ratio | 0.01 | 0.01 | 0.17 | 0.77 |
| Net Debt / FCF Ratio | 0.05 | 0.05 | 0.57 | 1.51 |
| Asset Turnover | 0.00 | 0.00 | ||
| Quick Ratio | 0.42 | 0.42 | 2.17 | 7.22 |
| Current Ratio | 0.44 | 0.44 | 2.20 | 7.39 |
| Return on Equity (ROE) | -871.42% | -871.42% | -65.29% | |
| Return on Assets (ROA) | -49.99% | -49.99% | -20.46% | |
| Return on Capital Employed (ROCE) | -89.20% | -89.20% | -35.20% | -18.40% |
| Earnings Yield | -509.09% | -24.90% | -9.80% | |
| FCF Yield | -7.78% | -3.86% | -2.73% | |
| Buyback Yield / Dilution | -3.01% | -2.36% |